Literature DB >> 10435580

Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.

T Hanke1, H Takizawa, C W McMahon, D H Busch, E G Pamer, J D Miller, J D Altman, Y Liu, D Cado, F A Lemonnier, P J Bjorkman, D H Raulet.   

Abstract

Mouse NK cells express at least seven inhibitory Ly49 receptors. Here we employ a semiquantitative cell-cell adhesion assay as well as class I/peptide tetramers to provide a comprehensive analysis of specificities of Ly49 receptors for class I MHC molecules in eight MHC haplotypes. Different Ly49 receptors exhibited diverse binding properties. The degree of class I binding was related to the extent of functional inhibition. The tetramer studies demonstrated that neither glycosylation nor coreceptors were necessary for class I binding to Ly49 receptors and uncovered peptide-specific recognition by a Ly49 receptor. The results provide a foundation for interpreting and integrating many existing functional studies as well as for designing tests of NK cell development and self-tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435580     DOI: 10.1016/s1074-7613(00)80082-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  94 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Authors:  Simon Bélanger; Megan M Tu; Mir Munir Ahmed Rahim; Ahmad B Mahmoud; Rajen Patel; Lee-Hwa Tai; Angela D Troke; Brian T Wilhelm; Josette-Renée Landry; Qinzhang Zhu; Kenneth S Tung; David H Raulet; Andrew P Makrigiannis
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

3.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 4.  Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules.

Authors:  Nazzareno Dimasi; Lorenzo Moretta; Roberto Biassoni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

6.  The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.

Authors:  Joshua N Beilke; Jonathan Benjamin; Lewis L Lanier
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

7.  Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner.

Authors:  Jayajit Das
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

8.  Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection.

Authors:  Tsukasa Nabekura; Lewis L Lanier
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

9.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

10.  Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.

Authors:  Can M Sungur; Yajarayma J Tang-Feldman; Erik Ames; Maite Alvarez; Mingyi Chen; Dan L Longo; Claire Pomeroy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.